Magnocellular Neurosecretory Cells, residing in the hypothalamus, are specialized neurons crucial for regulating various physiological processes through the release of hormones. These large cells are primarily classified into two groups: oxytocin-secreting cells and vasopressin-secreting cells. Oxytocin and vasopressin, both peptide hormones, play central roles in diverse functions such as uterine contractions during childbirth, lactation, social bonding, and water balance regulation. Magnocellular neurosecretory cells produce these hormones in response to specific stimuli and release them into the bloodstream via the posterior pituitary. The secretion of oxytocin and vasopressin is finely tuned by factors like stress, dehydration, and osmotic balance. Dysfunction in magnocellular neurosecretory cell activity can lead to disorders such as diabetes insipidus or inappropriate antidiuretic hormone secretion. Understanding the regulation of magnocellular neurosecretory cells is critical for unraveling the intricacies of neuroendocrine control and holds implications for reproductive health, water balance, and stress responses. Ongoing research seeks to further elucidate the molecular mechanisms governing these cells, offering potential insights into the development of therapeutic interventions for conditions associated with hormonal dysregulation.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy